29 results match your criteria: "Jimma University Laboratory of Drug Quality[Affiliation]"
Infect Drug Resist
February 2020
Jimma University Laboratory of Drug Quality (JuLaDQ), College of Health Sciences, Jimma University, Jimma, Ethiopia.
Background: Malaria is a complex disease and main community health problem in Africa and the top leading cause of outpatient visits, admissions, and deaths in Ethiopia. Its effective management is possible through early diagnosis and immediate treatment employing antimalarials. The quality of these drugs has to be good enough to attain their intended purpose.
View Article and Find Full Text PDFDrug Des Devel Ther
February 2020
Jimma University Laboratory of Drug Quality (JuLaDQ), Jimma University, Jimma, Ethiopia.
Background: Pharmaceuticals play a pivotal role in maintaining human health and promoting well-being. However, safety, efficacy, and quality of the drugs should be ascertained to provide a desired pharmacological effect.
Aim: The aim of the present study was to determine the quality as well as the physicochemical equivalence of nine brands of norfloxacin tablets marketed in Jimma, Ethiopia.
J Ethnopharmacol
March 2018
Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium. Electronic address:
Ethnopharmacological Relevance: Medicinal plants have always been an integral part of different cultures in Ethiopia in the treatment of different illnesses including malaria and related symptoms. However, due to lack of proper documentation, urbanization, drought, acculturation and deforestation, there is an increased risk of losing this traditional knowledge. Hence, the use of the indigenous knowledge should be well documented and validated for potential future use.
View Article and Find Full Text PDFActa Trop
July 2017
Jimma University, School of Medical Laboratory Sciences, Faculty of Health Sciences, Jimma University, Jimma, Ethiopia. Electronic address:
Nearly 40% of all malaria infection in Ethiopia is caused by Plasmodium vivax. Chloroquine (CQ) is the first line treatment for confirmed P. vivax malaria in the country.
View Article and Find Full Text PDF